May 14, 2026

India – Bombay High Court Directs Reconsideration Of Patent Application Due To Lack Of Sufficient Reasons For Refusal.

- DPS Parmar - Lex Orbis,

May 11, 2026

Unpacked: Singapore Court Of Appeal Clarifies Approach For Assessment Statutory Damages For Trade Mark Counterfeiting.

April 30, 2026

Malaysia – The Role Of Intellectual Property (IP) Policy In The Malaysian Public Sector.

April 28, 2026

India – Section 4 Refusal Of Patent ‘Sans Raison’ Set Aside By The Bombay High Court.

- Manisha Singh - Lex Orbis,

April 28, 2026

India – Infringement Analysis Based On Characterised Part Of Claim Not Justified: Division Bench Stays Interim Injunction Order.

- Manisha Singh - Lex Orbis,

April 28, 2026

India – Synergy Test Unmet: Delhi High Court Upholds Rejection Of Herbicidal Composition Patent.

- Manisha Singh - Lex Orbis,

April 28, 2026

Hong Kong – Safeguarding Your Brand: Preventing Distributors From Hijacking Your Hard-Earned Goodwill.

April 27, 2026

UK – Bird & Bird Advises Bodycare On National Retail Expansion.

April 23, 2026

Singapore – Shook Lin & Bok Recognised In The Best Lawyers 2027 Edition, With 14 Partners Named Across 11 Practice Areas.

April 22, 2026

Malaysia – Lessons On Moral Rights Of An Author From The Court Of Appeal Case Of Veronica Sainik @ Ronald V Meluha Life Sciences Sdn. Bhd. & Ors.

April 21, 2026

Philippines – Copying Comes At A Cost.

- Nilo T. Divina - DivinaLaw,

April 8, 2026

US – Trump Administration Imposes Section 232 Tariffs On Patented Pharmaceutical Imports; Tiered Rate Structure Takes Effect Beginning July 31, 2026.